SANOFI-AVENTIS (EPA:SAN) | WebDisclosure

Basculer en Français

10825	Companies
234833	Keywords
163651	Articles
125664	Press releases

Home
Companies
SANOFI-AVENTIS

PRESS RELEASE

published on 12/07/2024 at 17:30, 1 year 8 months ago

Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
Positive phase 3 study shows rilzabrutinib benefits in ITP patients. Results include platelet response, reduced bleeding, improved quality of life. Safety and efficacy highlighted

Phase 3 Study Rilzabrutinib ITP BTK Inhibitor Patient Benefit
BRIEF

published on 12/06/2024 at 07:35, 1 year 8 months ago

Sanofi Publishes Revised Financial Statements Excluding Opella

Financial Statements Biopharma Sanofi 2024 Results Opella
BRIEF

published on 12/06/2024 at 07:35, 1 year 8 months ago

Sanofi publie ses états financiers révisés excluant Opella

États Financiers Résultats 2024 Biopharma Sanofi Opella
PRESS RELEASE

published on 12/06/2024 at 07:30, 1 year 8 months ago

Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Sanofi releases revised financial statements excluding Opella. The adjustments classify Opella as discontinued operations, aligning with Sanofi's transition to a biopharma company. Q4 2024 results expected on Jan 30, 2025

Sanofi Discontinued Operations Opella Revised Financial Statements Biopharma Company
PRESS RELEASE

published on 12/06/2024 at 07:30, 1 year 8 months ago

Communiqué de presse : Mise en ligne des états financiers révisés de Sanofi hors Opella
Publication des états financiers révisés de Sanofi, hors Opella, suite à la cession de 50% à CD&R. Sanofi se recentre sur la biopharmacie et l'innovation

Cession États Financiers Sanofi Opella Biopharmacie
PRESS RELEASE

published on 10/25/2024 at 07:30, 1 year 9 months ago

Press Release: Sanofi Q3: 15.7% sales growth boosted by earlier-than-anticipated vaccine sales; 2024 business EPS guidance raised due to strong business performance
PRESS RELEASE

published on 10/25/2024 at 07:30, 1 year 9 months ago

Communiqué de presse : T3 2024 : Croissance des ventes de 15,7% soutenue par une séquence des ventes de vaccins plus favorable qu’anticipée; Sanofi relève ses perspectives de BNPA des activités 2024 suite à la forte performance
BRIEF

published on 10/24/2024 at 14:05, 1 year 9 months ago

Positive Phase 3 Data for Dupixent in Chronic Spontaneous Urticaria Released

Dupixent Chronic Spontaneous Urticaria Phase 3 Data ACAAI Presentation Treatment Innovation
BRIEF

published on 10/24/2024 at 14:05, 1 year 9 months ago

Publication de données positives de phase 3 pour Dupixent dans l'urticaire chronique spontanée

Dupixent Urticaire Chronique Spontanée Données De La Phase 3 Présentation De L'ACAAI Innovation En Matière De Traitement
PRESS RELEASE

published on 10/24/2024 at 14:00, 1 year 9 months ago

Press Release: Dupixent late-breaking positive phase 3 data in chronic spontaneous urticaria to be presented at ACAAI
Dupixent phase 3 data in chronic spontaneous urticaria presented at ACAAI shows reduced itch and hive activity, potential new treatment for CSU patients

Dupixent Chronic Spontaneous Urticaria ACAAI Phase 3 Data Targeted Treatment

Accesswire

Published on 08/12/2026 at 15:00, 25 minutes ago

Karbon-X and Core Energy Sign Letter of Intent to Explore Commercial EV Charging Infrastructure in South America
Published on 08/12/2026 at 14:45, 40 minutes ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Published on 08/12/2026 at 14:30, 55 minutes ago

Recent Corporate Events Recap
Published on 08/12/2026 at 14:00, 1 hour 25 minutes ago

International Battery Metals Appoints Scott Colangelo to Board of Directors
Published on 08/12/2026 at 13:55, 1 hour 30 minutes ago

Revive Therapeutics Reports Positive Results from DRDC Bucillamine Nerve-Agent Research Study

View all ACCESSWIRE

EQS Group

Published on 08/12/2026 at 15:07, 17 minutes ago

Original-Research: GFT TEchnologies SE (von Quirin Privatbank Kapitalmarktgeschäft): Buy
Published on 08/12/2026 at 15:05, 19 minutes ago

IGEL Partners with Menlo Security to Strengthen Zero Trust-Aligned Secure Access from Endpoint to Browser
Published on 08/12/2026 at 15:05, 19 minutes ago

Precisely Closes the SAP Automation Governance Gap with Automate Evolve Cloud Essentials
Published on 08/12/2026 at 15:05, 19 minutes ago

Stevie® Awards Announce 2026 International Business Awards® Winners from 78 Nations and Territories
Published on 08/12/2026 at 14:30, 55 minutes ago

Iute Group Reports Unaudited 6M 2026 Results on 27 August 2026 – Invitation to Earnings Webcast/Call on the Same Day

Les Echos

Published on 08/11/2026 at 17:45, 21 hours 40 minutes ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 21 hours 45 minutes ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 1 day 21 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 1 day 21 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
Published on 08/10/2026 at 17:45, 1 day 21 hours ago

Weekly share buyback

View all LES ECHOS COMFI WIRE